Cargando…
Radiotherapy is associated with a deletion signature that contributes to poor outcomes in cancer patients
Ionizing radiation causes DNA damage and is a mainstay for cancer treatment, but we have limited understanding of its genomic impact. We analyzed mutational spectra following radiotherapy in 190 paired primary and recurrent gliomas from the Glioma Longitudinal Analysis (GLASS) Consortium and 3,693 p...
Autores principales: | Kocakavuk, Emre, Anderson, Kevin J., Varn, Frederick S., Johnson, Kevin C., Amin, Samirkumar B., Sulman, Erik. P., Lolkema, Martijn P., Barthel, Floris P., Verhaak, Roel G.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483261/ https://www.ncbi.nlm.nih.gov/pubmed/34045764 http://dx.doi.org/10.1038/s41588-021-00874-3 |
Ejemplares similares
-
Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas
por: Kocakavuk, Emre, et al.
Publicado: (2023) -
Molecular and clonal evolution in recurrent metastatic gliosarcoma
por: Anderson, Kevin J., et al.
Publicado: (2020) -
TumorFusions: an integrative resource for cancer-associated transcript fusions
por: Hu, Xin, et al.
Publicado: (2018) -
Reconstructing the molecular life history of gliomas
por: Barthel, Floris P., et al.
Publicado: (2018) -
OMRT-3. Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment
por: Varn, Frederick, et al.
Publicado: (2021)